Mark Anderson

Scientific Manager, Department of In Vitro Sciences, Charles River

Mark has 27 years of experience working in a pharmaceutical research environment. As a Senior Scientist in the electrophysiology group at Organon Laboratories Limited, he designed, managed, planned and organized in vitro cardiovascular safety screening in recombinant cell systems using conventional patch clamp and automated systems. As Scientific Manager at Charles River, he manages the in vitro safety pharmacology assays in electrophysiology, primary hERG, as well as develops new models to support safety screening requirements. He is a member of the Safety Pharmacology Society.